|Series B, 6/2010 |
Burrill & Company
MP Healthcare Venture Management
|Debt, 2/2012 ||$3M|
Ferrokin Biosciences Inc. develops and markets medical devices. The company offers iron chelator for the treatment of iron-overload in patients with transfusion-dependent hereditary and acquired refractory anemias.
The company is based in San Carlos, California.